Contrasting In Vitro Activity of Nitroxoline Against Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolates from Outpatients
Antibiotics · 08.05.2026 · 15 (5) · 479
DOI: 10.3390/antibiotics15050479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 08.05.2026. Verfasst von Dominik Maleš und 3 weiteren Autor:innen. Beteiligte Einrichtung: Teaching Institute for Public Health, Split-Dalmatia County, 21000 Split, Croatia. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIP Pharma Croatia.
Abstract (Originalsprache)
Background/Objectives: Antimicrobial resistance is a major public health concern, particularly among multidrug-resistant (MDR) Enterobacterales. Nitroxoline is an older antibiotic with a unique mechanism of action that has not been widely used in recent decades. This study aimed to evaluate the in vitro activity of nitroxoline against Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia coli (E. coli) and MDR Klebsiella pneumoniae (K. pneumoniae) isolated from urine samples of outpatients in Split-Dalmatia County, Croatia.
Methods
Nitroxoline susceptibility was assessed using disk diffusion for E. coli (n = 26) and broth microdilution for K. pneumoniae (n = 33).
Results
ESBL-producing E. coli isolates showed high susceptibility to nitroxoline, with 25 (96.2%) classified as susceptible. In contrast, K. pneumoniae isolates exhibited high minimum inhibitory concentration (MIC) values (range 16–128 mg/L; median 32 mg/L), indicating limited activity.
Conclusions
Nitroxoline demonstrated strong in vitro activity against ESBL-producing E. coli but limited activity against MDR K. pneumoniae. Interpretation of the findings for K. pneumoniae is constrained by the lack of established clinical breakpoints.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Teaching Institute for Public Health, Split-Dalmatia County, 21000 Split, Croatia.
- General Hospital of Šibenik-Knin County, 22000 Sibenik, Croatia.
- Study Program of Dental Medicine, School of Medicine, University of Split, 21000 Split, Croatia.
- University of Split, Faculty of Health Sciences, 21000 Split, Croatia.
- School of Medicine, University of Split, 21000 Split, Croatia.
- ESCMID Food-and-Waterborne Infections Study Group, 4051 Basel, Switzerland.
ORCID-Profile: Dominik Maleš, Darko Kero, Merica Carev
Förderung
- MIP Pharma Croatia
Zitieren
APA
Maleš, D., Barišić, Z., Kero, D., & Carev, M. (2026). Contrasting In Vitro Activity of Nitroxoline Against Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolates from Outpatients. Antibiotics, 15(5), 479. https://doi.org/10.3390/antibiotics15050479
Vancouver
Maleš D, Barišić Z, Kero D, Carev M. Contrasting In Vitro Activity of Nitroxoline Against Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolates from Outpatients. Antibiotics. 2026;15(5):479. doi:10.3390/antibiotics15050479
BibTeX
@article{Male2026,
author = {Maleš, Dominik and Barišić, Zvonimir and Kero, Darko and Carev, Merica},
title = {Contrasting In Vitro Activity of Nitroxoline Against Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolates from Outpatients},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {5},
pages = {479},
doi = {10.3390/antibiotics15050479}
}
EUVIMED